Principal Technologies, Inc. engages in the operations in healthcare technology including the project management of international scale clinical studies primarily related to medical device technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2018-11-01. The firm is engaged in building a diverse portfolio of investments in healthcare technology companies with a focus on those with global distribution potential which have intellectual property capable of enhancing medical treatment quality, cost efficiency, optimization of the patient pathway, and implementation of point of care technologies. The firm operates through the health-care technology segment, including the project management of international scale clinical studies primarily related to medical device technologies. Its subsidiaries include Principal Technologies Capital Management GmbH and E&E CRO Consulting GmbH.
PTEKF stock price ended at $0.25 on 金曜日, after dropping 7.41%
On the latest trading day Jun 27, 2025, the stock price of PTEKF fell by 7.41%, dropping from $0.27 to $0.25. During the session, the stock saw a volatility of 22.73%, with prices oscillating between a daily low of $0.22 and a high of $0.27. On the latest trading day, the trading volume for PTEKF decreased by 8.7K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 10.8K shares were traded, with a market value of approximately $12.1M.